Evidence map›Paper›PMID 19941827›Full record

ArticleMolecular cell2009

Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis.

Ming Yu, Laura Riva, Huafeng Xie, Yocheved Schindler, Tyler B Moran, Yong Cheng, Duonan Yu, Ross Hardison, Mitchell J Weiss, Stuart H Orkin and 3 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Molecular cell, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 219 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
219citing papers in PubMed, 2 pooled it
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

219 citing papers in PubMed, 2 syntheses or guidelines pooled it, 313 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Article
  4. Article
  5. Article
  6. eLife · 2025
    Article
  7. Article
  8. bioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Pathogenic GATA2 genetic variants utilize an obligate enhancer mechanism to distort a multilineage differentiation program.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Article

159 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Ming YuDepartment of Pediatric Hematology-Oncology, Children's Hospital Boston and Dana-Farber Cancer Institute, Harvard Medical School, MA 02115, USA.
Laura Riva
Huafeng Xie
Yocheved Schindler
Tyler B Moran
Yong Cheng
Duonan Yu
Ross Hardison
Mitchell J Weiss
Stuart H Orkin
Bradley E Bernstein
Ernest Fraenkel
Alan B Cantor
Dana-Farber Cancer Institute · USChildren's Hospital of Philadelphia · USHarvard University · USMassachusetts Institute of Technology · USPennsylvania State University · US

Funding

TRANSCRIPTION FACTOR GATA-1 IN TERMINAL ERYTHROID DEVELOPMENTP01HL032262 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI ORKIN, STUART H · 1985 to 2021
$38.9M
Global Predictions and Tests of Erythroid RegulationR01DK065806 · NIDDK · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI BLOBEL, GERD A, CHIAROMONTE, FRANCESCA · 2004 to 2013
$5.3M
NHLBI NIH HHS P01 HL032262NHLBI NIH HHS P01 HL32262-25NIDDK NIH HHS R01 DK065806
6 · The paper itself

Abstract

The transcription factor GATA-1 is required for terminal erythroid maturation and functions as an activator or repressor depending on gene context. Yet its in vivo site selectivity and ability to distinguish between activated versus repressed genes remain incompletely understood. In this study, we performed GATA-1 ChIP-seq in erythroid cells and compared it to GATA-1-induced gene expression changes. Bound and differentially expressed genes contain a greater number of GATA-binding motifs, a higher frequency of palindromic GATA sites, and closer occupancy to the transcriptional start site versus nondifferentially expressed genes. Moreover, we show that the transcription factor Zbtb7a occupies GATA-1-bound regions of some direct GATA-1 target genes, that the presence of SCL/TAL1 helps distinguish transcriptional activation versus repression, and that polycomb repressive complex 2 (PRC2) is involved in epigenetic silencing of a subset of GATA-1-repressed genes. These data provide insights into GATA-1-mediated gene regulation in vivo.

Indexed as

AnimalsBase SequenceBinding SitesBiotinBiotinylationCell Line, TumorChromatinChromatin ImmunoprecipitationComputational BiologyGATA1 Transcription FactorGene Expression ProfilingGene Expression Regulation, LeukemicGene SilencingGenomeMiceModels, GeneticBiotinChromatinGata1 protein, mouseGATA1 Transcription FactorPolycomb-Group ProteinsRepressor ProteinsStreptavidin

Identifiers

PMID19941827
PMCPMC2800995
OpenAlexW2025129963

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.